PARP1 and cancer: In this study we performed a comprehensive analysis of 5371 tumors representing 15 cancer types, to investigate the distribution of previously characterized genomic scars associated with HR deficiency, a DNA repair deficiency that causes increased sensitivity to platinum-based genotoxic chemotherapy and PARP inhibitors [15].